PDPieter C. Dagnelie

Pieter C. Dagnelie

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Pieter C. Dagnelie has a total of 263 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Circulating Neutrophil and Monocyte Counts Are Inversely Associated With Heart Rate Variability Indices: The Maastricht Study

    by Haifa Maalmi, Kristiaan Wouters, Nicolaas C. Schaper, Anna Zhu, Jordi Heijman, Carla J. H. van der Kallen, Marleen M. J. van Greevenbroek, Pieter C. Dagnelie, Bastiaan E. de Galan, Anke Wesselius, et al.

    Background: Inflammatory biomarkers, including immune cells appear associated with reduced heart rate variability (HRV), an indicator of cardiac autonomic nervous dysfunction. However, the influence of leukocytes on HRV and their relation across sex and glucose metabolism status remains unclear. Hence, we sought to investigate the cross‐sectional association between leukocytes and HRV indices and their association across sex and glucose metabolism status in a general population. Methods: We retrieved cross‐sectional data of 1888 participants of the Maastricht Study who completed the baseline survey between November 2010 and December 2017. Blood leukocyte numbers (including neutrophils, monocytes, basophils, eosinophils, and lymphocytes) were determined with an automated hematology analyzer. Qualitative changes within lymphocytes were assessed with flow cytometry. HRV indices were assessed using a 24‐hour ECG. Time‐domain and frequency‐domain HRV index average scores were calculated. We regressed HRV average scores on standardized leukocytes and adjusted the models for several covariates. Results: In fully adjusted models, higher neutrophil (−0.07 [−0.11 to −0.03]; false discovery rate (FDR)‐corrected P value, P FDR =0.006) and monocyte (−0.05 [−0.09 to −0.02]; P FDR =0.020) counts were associated with a lower time‐domain average score. Higher neutrophil (−0.07 [−0.11 to −0.03]; P FDR =0.006) and monocyte (−0.05 [−0.09 to −0.01]; P FDR =0.020) counts were also associated with a lower frequency‐domain HRV index average score. No effect modification by either sex or glucose metabolism status was found ( P intFDR >0.05). There were no other associations between immune cells and HRV indices. Conclusions: Higher neutrophil and monocyte counts were associated with lower HRV, irrespective of sex and glucose metabolism status. This suggests a role of these cells reflecting innate immune processes and inflammatory response in cardiac autonomic nervous dysfunction.

  • Liver fat content is not elevated in people with type 1 diabetes: the Maastricht Study

    by Nefeli M. Dimitropoulou, Magdalena Beran, Simone J. P. M. Eussen, Cassy F. Dingena, Pieter C. Dagnelie, Carla J. H. van der Kallen, Annemarie Koster, Marleen M. J. van Greevenbroek, Martijn C. G. J. Brouwers, Miranda T. Schram, et al.

    Aim/hypothesis Obesity and poor dietary habits are thought to explain high liver fat content in type 2 diabetes, but they are increasingly common among individuals with type 1 diabetes. Whether people with type 1 diabetes are at an increased risk of liver fat accumulation remains unclear. We aimed to compare liver fat content in people with type 1 diabetes, with type 2 diabetes and without diabetes. Methods Data were derived from The Maastricht Study, a population-based cohort study. We matched people with type 1 diabetes to those with type 2 diabetes and those with normal glucose metabolism (1:2:2 matching) based on BMI, sex, age and educational level. MRI was used to estimate liver fat content. Liver fat data were log-transformed. We performed multiple linear regression analyses to compare the liver fat content between the three groups, adjusted for potential confounders including CVD risk factors, lifestyle, dietary factors, insulin use and estimated glucose disposal rate (eGDR). Results We included 29 individuals with type 1 diabetes, 58 with type 2 diabetes and 58 with normal glucose metabolism. The median liver fat content in type 1 diabetes was lower than in type 2 diabetes (2.1% [IQR 1.1–3.3] vs 4.9% [IQR 2.2–9.6], p=0.001), but did not differ from that in individuals with normal glucose metabolism (2.6% [IQR 1.8–3.8], p=0.064). The difference in liver fat content between the two diabetes groups was independent of BMI, lifestyle factors, CVD risk factors and dietary factors, but attenuated after adjustment for eGDR and insulin treatment. Conclusions/interpretation The liver fat content of individuals with type 1 diabetes was comparable to that of people without diabetes and lower than that in those with type 2 diabetes. This difference was independent of the level of obesity, dietary factors and other potential confounders, but was partially explained by insulin sensitivity and insulin treatment. Graphical Abstract


  • Open Access

    Forns index and fatty liver index, but not FIB-4, are associated with indices of glycaemia, pre-diabetes and type 2 diabetes: analysis of The Maastricht Study

    by Leen Heyens, Hanna Kenjic, Pieter Dagnelie, Casper Schalkwijk, Coen Stehouwer, Steven Meex, Jeroen Kooman, Otto Bekers, Marleen van Greevenbroek, Hans Savelberg, et al.

    Objective Glucose metabolism status (GMS) is linked to non-alcoholic fatty liver disease (NAFLD). Higher levels of advanced glycation end products (AGEs) are observed in people with type 2 diabetes mellitus (T2DM) and NAFLD. We examined the association between GMS, non-invasive tests and AGEs, with liver steatosis and fibrosis. Methods Data from The Maastricht Study, a population-based cohort, were analysed. Participants with alcohol overconsumption or missing data were excluded. GMS was determined via an oral glucose tolerance test. AGEs, measured by skin autofluorescence (SAF), were assessed using an AGE Reader. Associations of GMS and SAF with the fibrosis-4 score (FIB-4), Forns index (FI) and fatty liver index (FLI) were investigated using multivariable linear regression, adjusted for sociodemographic, lifestyle and clinical variables. Results 1955 participants (56.6%) were analysed: 598 (30.6%) had T2DM, 264 (13.5%) had pre-diabetes and 1069 (54.7%) had normal glucose metabolism. Pre-diabetes was significantly associated with FLI (standardised regression coefficient (Stβ) 0.396, 95% CI 0.323 to 0.471) and FI (Stβ 0.145, 95% CI 0.059 to 0.232) but not FIB-4. T2DM was significantly associated with FLI (Stβ 0.623, 95% CI 0.552 to 0.694) and FI (Stβ 0.307, 95% CI 0.226 to 0.388) but not FIB-4. SAF was significantly associated with FLI (Stβ 0.083, 95% CI 0.036 to 0.129), FI (Stβ 0.106, 95% CI 0.069 to 0.143) and FIB-4 (Stβ 0.087, 95% CI 0.037 to 0.137). Conclusion The study showed that adverse GMS and higher glycaemia are positively associated with steatosis. FI, but not FIB-4, was related to adverse GMS concerning fibrosis. This study is the first to demonstrate that SAF is positively associated with steatosis and fibrosis.


  • Open Access

    Estimated stearoyl-CoA desaturase activity mediates the associations of total cysteine with adiposity: The Maastricht Study

    by Elena C. Tore, Bregje C. Adriaans, Thomas Olsen, Kathrine J. Vinknes, M. Eline Kooi, Amany K. Elshorbagy, Nasser E. Bastani, Pieter C. Dagnelie, Simone J.P.M. Eussen, Thomas E. Gundersen, et al.


  • Open Access

    Nutritional status as independent prognostic factor of outcome and mortality until five years after hip fracture: a comprehensive prospective study

    by P.C. Dagnelie, P.C. Willems, N.R. Jørgensen

    Summary We determined the prognostic value of nutritional status for outcome after hip fracture. Nutritional status was a strong independent prognostic factor for clinical outcome and 5-year mortality. Physical function showed incomplete recovery. Elderly care should focus on prevention already before hip fracture. Purpose To determine the prognostic value of nutritional status in hip fracture patients for multiple clinical and functional outcomes over 6 months, and for new fractures and survival over 5 years post-fracture. Methods We included 152 well-characterized subjects (age 55+ years) with a hip fracture from a previously published randomized controlled trial. Nutritional status was appraised using the Mini Nutritional Assessment (MNA). Multivariable linear, logistic and Cox regression models were fitted, adjusted for age, sex, ASA score, group and additional prognostic covariates identified in backward regression models. Results At baseline, impaired nutritional status was significantly associated with physical disability, depression, impaired cognition and lower quality of life. Prospective analyses showed that impaired baseline nutritional status was an independent prognostic factor for postoperative complications (OR 2.00, 95%CI 1.01–3.98, p = 0.047), discharge location from hospital (home vs. rehabilitation clinic, OR 0.41, 95%CI 0.18–0.98, p = 0.044), hospital readmission (OR 4.59, 95%CI 1.70–12.4, p = 0.003) and total length of hospital stay (HR of being discharged: 0.63, 96%CI 0.44–0.89, p = 0.008), as well as for 5-year mortality (HR 3.94, 95%CI 1.53–10.2, p = 0.005), but not for risk of new fractures (5y-HR 0.87, 95%CI 0.34–2.24, p = 0.769). Curves of physical disability over time showed that the three nutritional status categories followed almost parallel trajectories from baseline until 6 months after hip fracture, without complete recovery and even with further deterioration in malnourished subjects from 3 to 6 months post-fracture. Conclusion As baselline nutritional status is a strong independent prognostic factor for clinical outcome after hip fracture, affecting even five-year survival, elderly health care should focus on prevention and identification of at-risk individuals already before hip fracture.


  • Open Access

    (Pre)diabetes and a higher level of glycaemic measures are continuously associated with corneal neurodegeneration assessed by corneal confocal microscopy: the Maastricht Study

    by Sara B. A. Mokhtar, Frank C. T. van der Heide, Karel A. M. Oyaert, Carla J. H. van der Kallen, Tos T. J. M. Berendschot, Fabio Scarpa, Alessia Colonna, Bastiaan E. de Galan, Marleen M. J. van Greevenbroek, Pieter C. Dagnelie, et al.

    Aims/hypothesis: To assess the associations between glucose metabolism status and a range of continuous measures of glycaemia with corneal nerve fibre measures, as assessed using corneal confocal microscopy. Methods: We used population-based observational cross-sectional data from the Maastricht Study of N=3471 participants (mean age 59.4 years, 48.4% men, 14.7% with prediabetes, 21.0% with type 2 diabetes) to study the associations, after adjustment for demographic, cardiovascular risk and lifestyle factors, between glucose metabolism status (prediabetes and type 2 diabetes vs normal glucose metabolism) plus measures of glycaemia (fasting plasma glucose, 2 h post-load glucose, HbA1c, skin autofluorescence [SAF] and duration of diabetes) and composite Z-scores of corneal nerve fibre measures or individual corneal nerve fibre measures (corneal nerve bifurcation density, corneal nerve density, corneal nerve length and fractal dimension). We used linear regression analysis, and, for glucose metabolism status, performed a linear trend analysis. Results: After full adjustment, a more adverse glucose metabolism status was associated with a lower composite Z-score for corneal nerve fibre measures (β coefficients [95% CI], prediabetes vs normal glucose metabolism −0.08 [−0.17, 0.03], type 2 diabetes vs normal glucose metabolism −0.14 [−0.25, −0.04]; linear trend analysis showed a p value of 0.001), and higher levels of measures of glycaemia (fasting plasma glucose, 2 h post-load glucose, HbA1c, SAF and duration of diabetes) were all significantly associated with a lower composite Z-score for corneal nerve fibre measures (per SD: −0.09 [−0.13, −0.05], −0.07 [−0.11, −0.03], −0.08 [−0.11, −0.04], −0.05 [−0.08, −0.01], −0.09 [−0.17, −0.001], respectively). In general, directionally similar associations were observed for individual corneal nerve fibre measures. Conclusions/interpretation: To our knowledge, this is the first population-based study to show that a more adverse glucose metabolism status and higher levels of glycaemic measures were all linearly associated with corneal neurodegeneration after adjustment for an extensive set of potential confounders. Our results indicate that glycaemia-associated corneal neurodegeneration is a continuous process that starts before the onset of type 2 diabetes. Further research is needed to investigate whether early reduction of hyperglycaemia can prevent corneal neurodegeneration. Graphical


  • Open Access

    Traditional lifestyle factors partly mediate the association of socioeconomic position with intrahepatic lipid content: The Maastricht study

    by Zhewen Ren, Hans Bosma, Anke Wesselius, Simone J.P.M. Eussen, M. Eline Kooi, Carla J.H. van der Kallen, Annemarie Koster, Marleen M.J. van Greevenbroek, Pieter Dagnelie, Coen D.A. Stehouwer, et al.


  • Open Access

    Habitual intake of advanced glycation endproducts is not associated with worse insulin sensitivity, worse beta cell function, or presence of prediabetes or type 2 diabetes: The Maastricht Study

    by Armand M.A. Linkens, Simone J.M.P. Eussen, Alfons J.H.M. Houben, Andrea Mari, Pieter C. Dagnelie, Coen D.A. Stehouwer, Casper G. Schalkwijk


  • Open Access

    Daily Physical Activity Patterns and Their Associations with Cardiometabolic Biomarkers: The Maastricht Study

    by Tuija Leskinen, Valéria Lima Passos, Pieter C. Dagnelie, Hans H. C. M. Savelberg, Bastiaan E. DE Galan, Simone J. P. M. Eussen, Coen D. A. Stehouwer, Sari Stenholm, Annemarie Koster

    Purpose: This study aimed to identify physical activity patterns and examine their association with cardiometabolic biomarkers in a cross-sectional design. Methods: Overall 6072 participants (mean age, 60.2 yr; SD 8.6 yr, 50% women) from The Maastricht Study provided daily physical activity data collected with thigh-worn activPAL3 accelerometers. The patterns of daily physical activity over weekdays and weekend days were identified by using Group Based Trajectory Modeling. Cardiometabolic biomarkers included body mass index, waist circumference, office blood pressure, glucose, HbA1c, and cholesterol levels. Associations between the physical activity patterns and cardiometabolic outcomes were examined using the analyses of covariance adjusted for sex, age, education, smoking, and diet. Because of statistically significant interaction, the analyses were stratified by type 2 diabetes status. Results: Overall, seven physical activity patterns were identified: consistently inactive (21% of participants), consistently low active (41%), active on weekdays (15%), early birds (2%), consistently moderately active (7%), weekend warriors (8%), and consistently highly active (6%). The consistently inactive and low active patterns had higher body mass index, waist, and glucose levels compared with the consistently moderately and highly active patterns, and these associations were more pronounced for participants with type 2 diabetes. The more irregular patterns accumulated moderate daily total activity levels but had rather similar cardiometabolic profiles compared with the consistently active groups. Conclusions: The cardiometabolic profile was most favorable in the consistently highly active group. All patterns accumulating moderate to high levels of daily total physical activity had similar health profile suggesting that the amount of daily physical activity rather than the pattern is more important for cardiometabolic health.


  • Open Access

    Associations between plasma sulfur amino acids and specific fat depots in two independent cohorts: CODAM and The Maastricht Study

    by Elena C. Tore, Amany K. Elshorbagy, Frans C. H. Bakers, Martijn C. G. J. Brouwers, Pieter C. Dagnelie, Simone J. P. M. Eussen, Jacobus F. A. Jansen, M. Eline Kooi, Yvo H. A. M. Kusters, Steven J. R. Meex, et al.

    Purpose: Sulfur amino acids (SAAs) have been associated with obesity and obesity-related metabolic diseases. We investigated whether plasma SAAs (methionine, total cysteine (tCys), total homocysteine, cystathionine and total glutathione) are related to specific fat depots. Methods: We examined cross-sectional subsets from the CODAM cohort (n = 470, 61.3% men, median [IQR]: 67 [61, 71] years) and The Maastricht Study (DMS; n = 371, 53.4% men, 63 [55, 68] years), enriched with (pre)diabetic individuals. SAAs were measured in fasting EDTA plasma with LC–MS/MS. Outcomes comprised BMI, skinfolds, waist circumference (WC), dual-energy X-ray absorptiometry (DXA, DMS), body composition, abdominal subcutaneous and visceral adipose tissues (CODAM: ultrasound, DMS: MRI) and liver fat (estimated, in CODAM, or MRI-derived, in DMS, liver fat percentage and fatty liver disease). Associations were examined with linear or logistic regressions adjusted for relevant confounders with z-standardized primary exposures and outcomes. Results: Methionine was associated with all measures of liver fat, e.g., fatty liver disease [CODAM: OR = 1.49 (95% CI 1.19, 1.88); DMS: OR = 1.51 (1.09, 2.14)], but not with other fat depots. tCys was associated with overall obesity, e.g., BMI [CODAM: β = 0.19 (0.09, 0.28); DMS: β = 0.24 (0.14, 0.34)]; peripheral adiposity, e.g., biceps and triceps skinfolds [CODAM: β = 0.15 (0.08, 0.23); DMS: β = 0.20 (0.12, 0.29)]; and central adiposity, e.g., WC [CODAM: β = 0.16 (0.08, 0.25); DMS: β = 0.17 (0.08, 0.27)]. Associations of tCys with VAT and liver fat were inconsistent. Other SAAs were not associated with body fat. Conclusion: Plasma concentrations of methionine and tCys showed distinct associations with different fat depots, with similar strengths in the two cohorts.